Drug
Eperisone clinical trials
How studies write it
Studies that test it under each name
Name
- Eperisone
- 2
Studies by the year they started
5 studies that test it; most in 2011 (2)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2011 | 2 |
| 2014 | 1 |
| 2017 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 1
Eisai Co., Ltd. (2) · First Affiliated Hospital of Zhejiang University (1) · Daewon Pharmaceutical Co., Ltd. (1) · Eisai Inc. (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Calcium Channel Blockers source
- One of Cholinergic Antagonists source
- One of Parasympatholytics source
Studies
Open first, then newest update. How each study uses eperisone is read from its arms, and is right about nine times in ten.
Testing it · 5
- Radial Extracorporeal Shock Wave Therapy for Chronic Non-specific Low Back PainCompletedNot applicableFirst Affiliated Hospital of Zhejiang UniversityNCT03337607Written as Eperisone
- Phase 3 Study to Evaluate the Efficacy and Safety of DW-1030 and Eperisone HCl in Acute Back Pain PatientsCompletedPhase 3Daewon Pharmaceutical Co., Ltd.NCT02040415Written as DW-1030(eperisone HCl) 75mg
- A Clinical Study in Healthy Male Volunteers to Compare the Bioequivalence of Fixed Dose Combination of Eperisone Hydrochloride 50mg Plus Diclofenac Sodium 50mg as Capsule With Eperisone Hydrochloride 50mg and Diclofenac Sodium 50mg Tablets Under Fasting Conditions (Study 013-10)CompletedNot applicableEisai Co., Ltd.NCT01306318Written as eperisone hydrochloride plus diclofenac sodium capsule
- Evaluation of Eperisone HCl in the Treatment of Acute Musculoskeletal Spasm Associated With Low Back Pain - A Double Blind, Randomised, Placebo Controlled Clinical TrialCompletedPhase 3Eisai Inc.NCT00327730Written as Eperisone
- A Clinical Trial to Study the Effects of a Fixed Dose Combination of Diclofenac and Eperisone Hydrochloride With Plain Eperisone Hydrochloride in Patients With Low Back PainCompletedPhase 3Eisai Co., Ltd.NCT01300312Written as Eperisone hydrochloride and Diclofenac sodium
Codes
What other systems call eperisone · ClinicalTrials.gg INT002933
- MeSH (NLM) C030848eperisoneConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 2M2P0551D3EPERISONEConfirmed FDA, NLM, Wikidata
- Wikidata Q426401eperisoneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C83692EperisoneOne source FDA
- DrugBank DB08992One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C030848 | eperisone | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 2M2P0551D3 | EPERISONE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q426401 | eperisone | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C83692 | Eperisone | One source FDA |
| DrugBank | DB08992 | — | One source Wikidata |
Also registered as eperisone hydrochloride (UNII U38O8U7P6X).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.